p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells

FEBS Letters

Volumn 579, Issue 22, 2005, Pages 5084-5088

  Herrera, Blanca ^a   Carracedo, Arkaitz ^a   Diez Zaera, María ^a   Guzmán, Manuel ^a   Velasco, Guillermo ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Apoptosis; Cannabinoids; CB2 receptor; p38 MAPK

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; MITOGEN ACTIVATED PROTEIN KINASE; RIMONABANT; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

APOPTOSIS; CASPASES; ENZYME ACTIVATION; HUMANS; JURKAT CELLS; LEUKEMIA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PSYCHOTROPIC DRUGS; RECEPTOR, CANNABINOID, CB2; TETRAHYDROCANNABINOL;

EID: 24144455626     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.08.021     Document Type: Article

References (25)

1. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949
2. R. Mechoulam, S. Ben-Shabat, L. Hanus, M. Ligumsky, N.E. Kaminski, A.R. Schatz, A. Gopher, S. Almog, B.R. Martin, D.R. Compton, R.G. Pertweee, G. Griffine, M. Bayewitchf, J. Bargf, and Z. Vogelf Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem. Pharmacol. 50 1995 83 90
3. A.C. Howlett, F. Barth, T.I. Bonner, G. Cabral, P. Casellas, W.A. Devane, C.C. Felder, M. Herkenham, K. Mackie, B.R. Martin, R. Mechoulam, and R.G. Pertwee International Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol. Rev. 54 2002 161 202
4. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65
5. I. Galve-Roperh, C. Sanchez, M.L. Cortes, T.G. del Pulgar, M. Izquierdo, and M. Guzman Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation Nat. Med. 6 2000 313 319
6. M.L. Casanova, C. Blazquez, J. Martinez-Palacio, C. Villanueva, M.J. Fernandez-Acenero, J.W. Huffman, J.L. Jorcano, and M. Guzman Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors J. Clin. Invest. 111 2003 43 50
7. S.A. Golech, R.M. McCarron, Y. Chen, J. Bembry, F. Lenz, R. Mechoulam, E. Shohami, and M. Spatz Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors Brain Res. Mol. Brain Res. 132 2004 87 92
8. V. Di Marzo, M. Bifulco, and L. De Petrocellis The endocannabinoid system and its therapeutic exploitation Nat. Rev. Drug Discov. 3 2004 771 784
9. D. Piomelli The molecular logic of endocannabinoid signalling Nat. Rev. Neurosci. 4 2003 873 884
10. M. Guzman Cannabinoids: potential anticancer agents Nat. Rev. Cancer 3 2003 745 755
11. C. Sanchez, M.L. de Ceballos, T.G. del Pulgar, D. Rueda, C. Corbacho, G. Velasco, I. Galve-Roperh, J.W. Huffman, S. Ramon y Cajal, and M. Guzman Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor Cancer Res. 61 2001 5784 5789
12. R.J. McKallip, C. Lombard, M. Fisher, B.R. Martin, S. Ryu, S. Grant, P.S. Nagarkatti, and M. Nagarkatti Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease Blood 100 2002 627 634
13. M. Bouaboula, C. Poinot-Chazel, B. Bourrie, X. Canat, B. Calandra, M. Rinaldi-Carmona, G. Le Fur, and P. Casellas Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1 Biochem. J. 312 1995 637 641
14. P. Derkinderen, C. Ledent, M. Parmentier, and J.A. Girault Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus J. Neurochem. 77 2001 957 960
15. J. Liu, B. Gao, F. Mirshahi, A.J. Sanyal, A.D. Khanolkar, A. Makriyannis, and G. Kunos Functional CB1 cannabinoid receptors in human vascular endothelial cells Biochem. J. 346 2000 835 840
16. D. Rueda, I. Galve-Roperh, A. Haro, and M. Guzman The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase Mol. Pharmacol. 58 2000 814 820
17. O. Cuvillier, L. Edsall, and S. Spiegel Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells J. Biol. Chem. 275 2000 15691 15700
18. M. Pique, M. Barragan, M. Dalmau, B. Bellosillo, G. Pons, and J. Gil Aspirin induces apoptosis through mitochondrial cytochrome c release FEBS Lett. 480 2000 193 196
19. J.W. Huffman, J. Liddle, S. Yu, M.M. Aung, M.E. Abood, J.L. Wiley, and B.R. Martin 3-(1′,1′-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor Bioorg. Med. Chem. 7 1999 2905 2914
20. W.S. Choi, D.S. Eom, B.S. Han, W.K. Kim, B.H. Han, E.J. Choi, T.H. Oh, G.J. Markelonis, J.W. Cho, and Y.J. Oh Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons J. Biol. Chem. 279 2004 20451 20460
21. T. Gomez del Pulgar, G. Velasco, C. Sanchez, A. Haro, and M. Guzman De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis Biochem. J. 363 2002 183 188
22. E.J. Downer, M.P. Fogarty, and V.A. Campbell Tetrahydrocannabinol-induced neurotoxicity depends on CB1 receptor-mediated c-Jun N-terminal kinase activation in cultured cortical neurons Br. J. Pharmacol. 140 2003 547 557
23. J. Gertsch, R. Schoop, U. Kuenzle, and A. Suter Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways FEBS Lett. 577 2004 563 569
24. S. Kumar, J. Boehm, and J.C. Lee p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases Nat. Rev. Drug Discov. 2 2003 717 726
25. Y. Do, R.J. McKallip, M. Nagarkatti, and P.S. Nagarkatti Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation J. Immunol. 173 2004 2373 2382